Oncology Global Strategic Marketing organizations face increasing challenges in a crowded oncology market. This study benchmarked the budget levels, service scope, and activities of GSM organizations from 17 pharmaceutical companies. Key findings include: 1) Large company GSM averages $805,231 per pipeline program and $6.2 million per marketed product. 2) Marketing and market intelligence account for over half of GSM budgets. 3) GSM most often leads in market intelligence activities across development phases. The study provides industry metrics for GSM budgeting and strategic planning.